// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Apabetalone (RVX-208) Alone and in Combination with Standard of Care Improves Experimental PAH in Sugen-Hypoxia Rat Model

E. Tremblay - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

RVX-208

Influenza A-Induced Pneumonia Accelerates Aging Related Cognitive Decline in Mouse Models

F. J. Gonzalez - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Repeatability, Reproducibility and Reliability of Respiratory System Impedance Assessed by Oscillometry: Effect of Cheek Support and Inappropriate Positioning of Head and Neck

U. Peters - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

A Systematic Analysis of Terminal Bronchiole Remodeling in COPD Patients with and Without Alpha-1 Antitrypsin Deficiency

D. M. Vasilescu - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

Alpha 1-Antitrypsin

Marijuana Smoking in the Middle-Aged and Elderly Population Is Associated with Rapid Decline in FEV1

W. Tan - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Salbutamol

Differences Between Sputum and Saliva Microbiome Profiles in COPD Patients Admitted for Acute Exacerbations

F. S. Leitao Filho - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Sputum Microbiome Is Associated with 1-Year Mortality in COPD Exacerbations

F. S. Leitao Filho - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Comparisons Between Sputum Molecular Pathogen Detection Methods and Microbiome Sequencing in COPD Exacerbations

F. S. Leitao Filho - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Transfusion Related Acute Lung Injury (TRALI) in Pediatric Intensive Care Unit: A Multicenter Cohort Study

G. Emeriaud - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Voxel-Wise Measurement of Lung Inflation Changes in Prone Vs. Supine Positions in Pigs with Lung Injury

Y. Xin - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Mesenchymal Stromal Cells Enhance IgG-Mediated Phagocytosis and Modulate Fcγ Receptor Expression and Binding Activity in Human Macrophages Partly Through Lipoxin A4/IL-10 Pathway

R. Rabani - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

Interleukin-10

Very Low Density (VLDL) and Low Density Lipoproteins (LDL) Mediate the Uptake of Pathogen Lipids and Stimulate the Production of IL-1β in THP-1 Macrophages

A. K. Leung - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparative Analysis of Oxidative Potential of Oil-Sands Secondary Organic Aerosol with Oxidative Stress and Inflammatory Response in Human Airway Epithelial Cells

X. Wang - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Nocturnal Variations in Supine Lung Volumes and Spirometry in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

N. Domnik - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Pro-Atherogenic Cytokine Profile of Patients with COPD and OSA Overlap Syndrome: A Pilot Study

A. Shah - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Adult Asthma Management Resources and Pathway Implementation in Ontario Emergency Departments

C. Kwok - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Distinct Patterns of Respiratory-Related Health Services Use and Risk Factors in the First Three Years of Life

W. Chen - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

The Relationship Between Eosinophil Count and Asthma Exacerbations

C. D. Ramsey - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Literature in Severe Asthma: Bronchial Thermoplasty and Biological Agents

T. Vandemoortele - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Mepolizumab

Development and Validation of a Constrained Values Clarification Tool for End of Life Care

A. Nijjar - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved